AICAR Peptide Dosage Guide, Benefits & Side Effects

Because AICAR has not been through human clinical trials for the uses it is marketed for online, there is no well-characterized human side-effect profile. Animal and limited clinical research (e.g., older cardiovascular surgery trials with acadesine) have reported issues such as gastrointestinal disturbance, changes in blood pressure, and effects on adenosine-related pathways. Injection-site reactions (pain, redness, swelling) are commonly mentioned for any subcutaneous research compound. Because AICAR broadly activates AMPK, there is theoretical concern about off-target metabolic and cardiovascular effects with unsupervised or repeated use. It should not be treated as a safe or medically vetted supplement.

As with most lyophilized (freeze-dried) research peptides, unopened AICAR vials are generally recommended to be kept refrigerated (2-8°C) for shorter-term storage or frozen (-20°C) for long-term storage, protected from light. Once reconstituted with bacteriostatic or sterile water, vendor guidance commonly suggests keeping the solution refrigerated and using it within about 2-4 weeks, avoiding repeated freeze-thaw cycles that can degrade the compound. These are general handling conventions from suppliers rather than standardized pharmacopeial storage data.

Both compounds increase AMPK activity but through different routes: metformin engages the cell's natural energy-sensing pathway indirectly (partly via mitochondrial complex I inhibition), while AICAR is converted intracellularly to ZMP, an AMP mimic that binds AMPK directly, bypassing the need for real energy stress. This makes AICAR a more direct pharmacological tool for activating AMPK in research settings, whereas metformin's effects are considered more physiologically integrated. They are studied together in comparative research on glucose uptake and insulin signaling, but neither is interchangeable with the other in terms of approved use or evidence base.

AICAR is sold by various research chemical and peptide vendors, typically as a lyophilized powder marketed strictly for laboratory or research use, not for human consumption. Because this space is loosely regulated, product purity, accurate labeling, and vendor reliability vary significantly, and independent third-party testing is not guaranteed. Buyers researching AICAR should be aware that purchasing it for personal use carries legal, quality-control, and safety uncertainties, and that no dosing or safety information from a vendor should be mistaken for medical advice.